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One Nucleotide in a B Site Can Determine
Cofactor Specificity for NF-B Dimers
the NF-B family are involved in gene activation: p50,
p52, p65, and cRel. They are the mature gene products
from four genes: nfkB1, nfkB2, relA, and rel, respectively,
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and they homo- or heterodimerize with one another toCalifornia Institute of Technology
bind DNA. It is noteworthy that mice deficient in a singlePasadena, California 91125
NF-B/Rel family member exhibit unique, largely non-
overlapping phenotypes. For instance, relA/ animals
are embryonic lethal and develop massive liver apopto-Summary
sis (Beg et al., 1995), while nfkB1/ mice develop nor-
mally but have deficits in immune function (Sha et al.,The transcription factor NF-B regulates a wide variety
1995).of genes involved in multiple processes. Although the
Past studies predominantly used transient-transfec-apparent consensus sequence of DNA binding sites
tion reporter systems with overexpressed NF-B pro-for NF-B (B sites) is very broad, the sites active in
teins to conclude that certain NF-B complexes bindany one gene show remarkable evolutionary stability.
particular NF-B binding sites (called B sites) preferen-Using a lentivirus-based methodology for implantation
tially (Fujita et al., 1992; Kunsch et al., 1992). When simi-of gene regulatory sequences we show that for genes
lar transient-transfection reporter assays were repeatedwith two B sites, both are required for activity. Swap-
in NF-B knockout cells, NF-B family members exhib-ping sites between B-dependent genes altered
ited no preference for particular B sequences (Hoff-NF-B dimer specificity of the promoters and revealed
mann et al., 2003). With increased knowledge aboutthat two B sites can function together as a module
transcriptional regulation, questions about the recruit-to regulate gene activation. Further, although the se-
ment of specific NF-B family members to a promoterquence of the B site is important for determining B
should be addressed within a physiological context.family member specificity, rather than determining the
Our previous study utilized a genetic approach toability of a particular dimer to bind effectively, the
study NF-B-dependent gene activation by creating asequence affects which coactivators will form produc-
panel of single and double NF-B knockout cell linestive interactions with the bound NF-B dimer. This
(Hoffmann et al., 2003). We showed there that TNF-suggests that binding sites may impart a specific con-
stimulated, B-dependent genes may require specificfiguration to bound transcription factors.
B family members for activation. Some genes had
stricter requirements than others. For example, any p65Introduction
or cRel-containing hetero- or homodimer could activate
the MCP-1 gene (scya2), while the LIF gene (lif) specifi-Study of mammalian gene transcription is often con-
cally required a p50:p65 heterodimer for activation. We
founded by the recognition of a single regulatory se-
were unable to document a strict correlation between
quence by multiple members of a transcription factor
B family member requirements and their B site se-
family. Expansion of the number of members in a partic- quences.
ular family may occur over evolutionary time suggesting Structural studies have also not revealed evidence
that particular members evolve to serve restricted func- for highly specific interactions between NF-B and its
tions in a complex organism. However, outside of the cognate DNA binding sites. B sites display a remark-
nuclear hormone receptor superfamily (Rastinejad, ably loose consensus sequence, often cited as G5G4
2001), little is known about how individual family mem- G3R2N1N0Y1Y1C2C3 (Ghosh et al., 1998). Crystal
bers provide specificity. structures have shown that p50 homodimers often inter-
NF-B is a dimeric protein that mediates cellular re- act specifically with 5-G5G4G3, while p65 homodi-
sponses to a wide variety of stimuli including TNF, mers interact specifically with 5-G5G4. X-ray struc-
LPS, IL-1, and ultraviolet light (Ghosh et al., 1998; Karin tures of p50:p65 heterodimers demonstrate that they
and Ben-Neriah, 2000; Karin et al., 2002). NF-B plays an can bind to a variety of B site sequences (Berkowitz
integral role in many important and diverse processes, et al., 2002; Chen and Ghosh, 1999; Chen-Park et al.,
including inflammatory responses, immune system de- 2002; Escalante et al., 2002). Taken together, structural
velopment, apoptosis, learning in the brain, and bone studies have not identified enough dimer-specific DNA
development. In resting cells, NF-B is held inactive via binding contacts to rationalize specific NF-B binding
associations with inhibitory proteins called inhibitors of sites and underscore the remarkable permissiveness in
NF-B (IB). When the cell is stimulated, IB proteins are NF-B-DNA interactions.
phosphorylated, ubiquitinated, and degraded, allowing In this study, we demonstrate that the sequence of
NF-B to bind DNA and activate appropriate target the B site does play an important role in determining
genes. B family member specificity. But rather than the site
In response to inflammatory stimuli, four members of determining the ability of a particular dimer to bind effec-
tively, we find that the sequence of the B site affects
which coactivators will form productive interactions with*Correspondence: baltimo@caltech.edu
the bound B dimer, suggesting that binding sites may2Present address: Signaling Systems Laboratory, Department of
Chemistry and Biochemistry, UCSD, La Jolla, California 92093 affect the configuration of the bound dimer.
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Figure 1. Functional B Site Sequences Are
Strictly Conserved and Activation of Lentiviral
MCP-1 Transgene Is Responsive to Stimuli
and Dependent on NF-B
Validated mouse and human B site se-
quences for eleven B-dependent genes were
compared using the Celera and Ensembl data-
bases (A). The B site sequences for all of the
eleven genes studied were 100% conserved
between mouse and human. Roughly 5 kb of
the MCP-1 gene promoter and a luciferase
reporter gene (ML M1M2) was implanted into
wild-type and p50/p65 knockout 3T3 cells by
lentiviral infection. Cells were stimulated with
TNFover a four hour time course. Four varia-
tions of the ML transgene are shown: a 5 kB
wild-type version “ML M1M2” (B), a version
with both B binding sites mutated to a null
sequence “ML N1N2” (C), a version where
the distal B binding site is intact and the
proximal site is mutated to a null sequence
“ML M1N2”(D, left image), and a version where
the distal binding site is mutated to a null
sequence and the proximal site is intact “ML
N1M2” (D, right image).
Results swap the sequences between two B-dependent genes
with different properties. The IP-10 (cxcl10) and MCP-1
genes were chosen for investigation. When IP-10 andB Site Sequences Are Strictly Conserved
between Mouse and Human MCP-1 respond to TNF, they have different B family
member requirements. MCP-1 mRNA is induced in bothTo understand whether the sequences of B sites play
a significant role in determining functional specificity, wild-type (wt) and p50/p52-deficient cells, while IP-10
mRNA is induced in wt cells but not p50/p52-deficientvalidated mouse and human B site sequences for
eleven B-dependent genes were compared using the cells (Hoffmann et al., 2003). p65 homodimers are the
only detectable dimer in p50/p52-deficient 3T3 cells.Celera and Ensembl databases (Hoffmann et al., 2003;
Libermann and Baltimore, 1990; Thanos and Maniatis, Therefore, both hetero- and homodimers of NF-B are
able to function on the MCP-1 promoter while only het-1995b). The B site sequences for all eleven genes stud-
ied were 100% conserved between mouse and human erodimers of NF-B appear able to activate IP-10. The
regulatory sequences of the genes have certain similari-(Figure 1A). In contrast, a pairwise sequence compari-
son program (Family Relations) revealed that the regions ties but significant differences. Based on previous work
as well as mouse/human sequence comparisons,surrounding the B sites often displayed 85% conser-
vation (data not shown) (Brown et al., 2002). If the se- MCP-1 and IP-10 each appear to have two functioning
B sites that are both required for gene activation (Oh-quence of the B site did not play a significant role in
determining functional specificity, we would have ex- mori and Hamilton, 1993, 1995; Ping et al., 1999). Both
genes are highly expressed in fibroblasts and are re-pected the sequence of some of the B sites to mutate
over time. We therefore decided to test whether the sponsive to multiple stimuli. However, the promoter ar-
chitecture for the two genes is strikingly different. IP-sequence of the B site can alter the functional proper-
ties of bound dimers. 10’s B sites are less than 200 bp from the transcription
start site while MCP-1’s functional B sites are moreTo address the role of B site sequence, we wanted to
Transcriptional Specificity of NF-B Dimers
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Figure 2. Swapping MCP-1 B Site Se-
quences for IP-10 B Site Sequences Im-
poses IP-10 B family Member Requirements
on the MCP-1 Promoter
IP-10 B site sequences (ML I1I2) were
swapped for the MCP-1 B site sequences
in the ML transgene by PCR mutagenesis.
Lentivirus was produced and applied to wild-
type and p50/p52 knockout 3T3 cells.
(A) compares the activity of the integrated ML
M1M2 transgene to the ML I1I2 transgene.
(B) shows the activity of the transgene when
one MCP-1 B binding site is swapped with
its corresponding IP-10 B binding site se-
quence (ML M1I2 or ML I1M2).
(C) compares the activity of the transgene
when either one of the IP-10 B sites are du-
plicated and inserted into the transgene (ML
I1I1 and ML I2I2). All cells were stimulated
with TNF over a four hour time course.
than 2.3 kb away from the transcription start site. (MCP-1 tion of the virus’ own promoter, ensuring that the in-
has another B-like sequence near the promoter, which serted regulatory sequence is the only such information
was shown to be nonfunctional and not conserved be- in the vector. We used a luciferase reporter gene to
tween mouse and human.) IRF-3 has been shown to be monitor transcriptional activity.
important in IP-10 gene regulation but not for MCP-1 To test the reporter system, we cloned 5 kb of the
(Sakaguchi et al., 2003). The B site sequences are not mouse MCP-1 gene promoter into the lentiviral con-
dramatically different between MCP-1 and IP-10. All struct. (We designate this ML M1M2, denoting its origin
sites are 10 bp long. The distal sites differ in one base from the MCP-1 gene, its use of a luciferase reporter
pair, and the proximal sites differ in two base pairs (Fig- gene, and its two B sites containing MCP-1-derived
ure 1A). sequence). Lentiviral stocks were prepared, concen-
trated by ultracentrifugation, and applied to either wt
mouse 3T3 cells or 3T3 cells lacking both p50 and p65Lentiviral-Based Reporter System Recapitulates
subunits (effectively NF-B null cells (Hoffmann et al.,Endogenous Gene Regulation
2003)). Routinely, multiple cell populations were createdTo effect the sequence interchanges, we needed a sys-
by infecting cells with serial dilutions of virus. Popula-tem that would allow us easy access for nucleotide alter-
tions that expressed low basal luciferase activityation but would retain the regulatory properties of the
(roughly 5-fold above background) were used for analy-endogenous gene promoters. The use of a retrovirus
sis to ensure a low number of integrated provirusesvector allows insertion of up to 7 kb of regulatory infor-
per cell.mation and permits sequence alteration at will. We
wt and p50/p65-deficient cells with the integrated MLchose a self-inactivating lentiviral vector system that
M1M2 transgene were stimulated with TNF (Figure 1B)infects both dividing and nondividing cells (Lois et al.,
2002). The self-inactivating characteristic involves dele- over a 4 hr time course. wt cells responded robustly,
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Figure 3. p65 Homodimer and p300/CBP Bind
to ML I1I2
Chromatin immunoprecipitation assays with
antibodies against p65 (A and B) and p300 (C
and D) demonstrate that p65 and p300 binds
the MCP-1 promoter, the IP-10 promoter, and
ML I1I2 transgene in a TNF-dependent man-
ner. The white line indicates where lanes irrel-
evant to the figure have been cropped (B).
while p50/p65-deficient cells had minimal inducible lu- quences were unresponsive to the homodimer, two
different MCP-1 promoter constructs containing dupli-ciferase activity, showing that the system recapitulates
the NF-B dependence shown previously for the in situ cated IP-10 B site sequences were made (ML I1I1,
ML I2I2, Figure 2C). wt cells infected with either MLgene. Next, the B sites within the ML transgene were
mutated to null B site sequences (ML N1N2). wt cells transgene remained responsive to TNF stimulation.
However, p50/p52-deficient cells carrying the ML I1I1carrying the integrated ML N1N2 transgene showed no
inducible luciferase activity following TNF treatment transgene were not responsive to TNF stimulation,
while those carrying the ML I2I2 transgene displayed(Figure 1C). Finally, two different constructs were cre-
ated with one B site left intact and the other B site inducible luciferase activity. Thus, the I1 or distal B
site of the IP-10 promoter determines the heterodimermutated to a null sequence (ML M1N2 and ML N1M2)
(Figure 1D). As previously shown (Ping et al., 1999), the requirement of the IP-10 promoter. The B site se-
quences in the ML I1I1 construct differ from those inmutation of either B site to a null sequence abrogated
inducible luciferase activity in wt cells. These transgenic the ML M1M2 construct only at the sixth nucleotide for
each site. Therefore, we can identify this single nucleo-cells lines were also stimulated with LPS, and the results
were similar to those with TNF (data not shown). Thus, tide as responsible for the difference in B family mem-
ber requirements.the ML M1M2 transgene is inducible by multiple stimuli
in a B-dependent fashion, and both B sites must be To exclude the possibility that nearby factors bound
to the MCP-1 promoter may affect B-dimer specificity,intact for the promoter to be functional.
lentiviral constructs containing only the c-fos minimum
promoter and the B sites from MCP-1 or IP-10 wereSwapping MCP-1 B Site Sequences for IP-10 B
tested. Upon TNF treatment, the construct containingSite Sequences Imposes IP-10 B Family Member
the MCP-1 B sites was responsive to hetero- and ho-Requirements on the MCP-1 Promoter
modimers of NF-B, while the construct containing IP-The B site sequences from the IP-10 promoter were
10 B sites only responded to heterodimers of NF-Bswapped into the ML M1M2 transgene by PCR to create
(data not shown).ML I1I2. wt cells infected with ML I1I2 were responsive
to TNF stimulation, but TNF-stimulated, ML I1I2-
infected, p50/p52-deficient cells displayed no inducible p65 and CBP Are Bound to the Inactive
ML I1I2 Transgene in TNF-Stimulatedluciferase activity (Figure 2A, right image). In contrast,
p50/p52-deficient cells infected with ML M1M2 dis- p50/p52-Deficient Cells
One possible explanation of the inability of the IP-10played inducible luciferase activity comparable to that
of wt cells (Figure 2A, left image). We conclude that the distal B site to respond to a homodimer of p65 would
be an inability of the site to bind the homodimers. ToML I1I2 transgene requires NF-B heterodimers for acti-
vation. address this possibility, we performed chromatin immu-
noprecipitation (ChIP) assays with an anti-p65 antibodyTo test whether the altered B family member require-
ments in ML I1I2 were dependent on one or both of the in TNF-stimulated wt and p50/p52-deficient cells con-
taining the ML I1I2 transgene. wt cells with the ML I1I2IP-10 B site sequences, two MCP-1 promoter con-
structs were created carrying one IP-10 B site and one transgene showed robust p65 binding after TNF stimu-
lation (Figure 3A). Surprisingly, p50/p52-deficient cellsMCP-1 B site (ML M1I2, ML I1M2, Figure 2B). Both wt
and p50/p52-deficient cells carrying these constructs with the ML I1I2 transgene also demonstrated p65 bind-
ing after TNF stimulation. Therefore, even though theremained responsive to TNF stimulation. Therefore,
either MCP-1 B site sequence alone is sufficient to ML I1I2 transgene shows minimal activity in TNF stimu-
lated p50/p52-deficient cells, p65 homodimers are stillprovide a response to the p65 homodimer.
To determine if one or both of the IP-10 B site se- bound to the promoter. Examination of the endogenous
Transcriptional Specificity of NF-B Dimers
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Figure 4. IP-10 B Binding Sites Display
Stimulus-Specific B Family Member Re-
quirements
Wild-type (wt) and p50/p52-deficient cells
were stimulated with LPS. IP-10 RNA tran-
script was measured by quantitative PCR (A).
1 kb of the IP-10 promoter was cloned into
the lentiviral transfer vector (IL). wt and p50/
p52 knockout cell lines with integrated IL
were stimulated with TNF or LPS (B). wt and
p50/p52 knockout cells integrated with the
ML I1I2 transgene were stimulated with TNF
or LPS (C).
IP-10 promoter gave a congruent result. In TNF-stimu- IP-10 promoter was cloned into our retrovirus vector (IL).
Consistent with the endogenous gene data, TNF-stimu-lated p50/p52-deficient cells, p65 was still bound to an
inactive IP-10 promoter (Figure 3B). lated wt cells with the integrated IL transgene displayed
induced luciferase activity, while p50/p52-deficient cellsIf p65 homodimers are bound to an inactive ML I1I2
transgene, the B site sequence might not support tran- with the IL transgene showed significantly lower activity
(Figure 4B, left image). In contrast, LPS-stimulated wtscription because the conformation of the p65 homodi-
mers might not recruit the appropriate coactivators to and p50/p52-deficient cells with the IL transgene dem-
onstrated similar luciferase activity (Figure 4B, right im-the promoter. One type of coactivator known to interact
with the transactivation domain of p65 is CBP/p300 (Per- age). Thus, the lentiviral system recapitulated the stimu-
lus-specific behavior of the endogenous IP-10 gene.kins et al., 1997; Sheppard et al., 1999). We performed
ChIP assays against p300 using TNF-stimulated, ML To be certain that the stimulus-specificity was deter-
mined by the B site, we went back to the chimericM1M2-infected, p50/p52-deficient cells and discovered
that p300 is recruited to the MCP-1 and IP-10 promoters transgenes. In fact, as opposed to the data with
TNF-stimulated cells, LPS-treated wt and p50/p52-in a stimulus-dependent manner (Figure 3C). Further-
more, we found that p300 was bound to the ML I1I2 deficient cells containing the ML I1I2 transgene dis-
played similar levels of luciferase induction (Figure 4C,transgene in TNF-stimulated p50/p52-deficient cells
(Figure 3D). Thus, this cofactor is recruited even though right image). Studies with the ML I1I1 transgene demon-
strated similar results (data not shown) and supportedthe promoter is not firing.
the conclusion that p65 homodimers are bound to the
I1 site. Taken together, these results confirmed that theIP-10 Displays Stimulus-Specific Requirements
for NF-B Family Members stimulus-specificity was a consequence of the B site
sequence and was consistent with the observation ofTo test whether the IP-10 gene shows the same hetero-
dimer requirement to an inducer other than TNF, wt, p65 homodimers bound to the ML I1I2 transgene. It
strongly suggested that the unresponsiveness of the IP-and p50/p52-deficient cells were stimulated with TNF
or LPS over a 6 hr time course, and IP-10 mRNA induc- 10 gene to homodimers in the TNF-treated cells is a
consequence of the lack of a cofactor that LPS cantion was assayed by quantitative PCR (Q-PCR). The
induction of IP-10 mRNA in TNF-stimulated wt and induce.
p50/p52-deficient cells recapitulated our previously
published ribonuclease protection assays showing the Overexpression of IRF-3 Rescues Induction
of ML I1I2 Transgene by TNFheterodimer requirement for activation (Figure 4A, left
image). In contrast, LPS-stimulated wt and p50/p52- To identify the LPS-specific factor that allows B homo-
dimers to activate the ML I1I2 transgene, we noted thatdeficient cells induced IP-10 mRNA to similar levels (Fig-
ure 4A, right image). Thus, the heterodimer requirement LPS signals through the TLR-4 receptor (Akira, 2003;
Takeda et al., 2003). TLR-4 downstream signaling isis an inducer-specific phenomenon.
To determine if the lentiviral-based reporter system divided into two distinct pathways, one mediated by
MyD88 and the other by Trif. Since IP-10 is induced bycould recapitulate IP-10’s stimulus-specificity, 1 kb of the
Cell
458
Figure 5. IRF-3 Is Recruited to the ML I1I2
Transgene and Required for Transgene Acti-
vation
IRF-3 and IRF-3 DBD were overexpressed
in wt and p50/p52 deficient cells carrying the
ML I1I2 transgene (A and B, respectively).
IRF-3 overexpressed cells were stimulated
with TNF. IRF-3 was knocked-down by RNAi
in p50/p52-deficient and wt cells carrying the
ML I1I2 transgene (C and D, respectively).
IRF-3 knocked-down cells were stimulated
with LPS. Chromatin immunoprecipitation
assays with antibodies against IRF-3 demon-
strate that IRF-3 is recruited to the IP-10 pro-
moter but not the MCP-1 promoter in a LPS-
dependent manner (E, left image). IRF-3 is
recruited to the ML I1I2 transgene in a LPS-
dependent manner (E, right image). The white
line indicates where lanes irrelevant to the
figure have been cropped.
LPS in MyD88-deficient fibroblasts (Yamamoto et al., c-Myc binding sites (Li et al., 2003). To test this hypothe-
sis, an expression vector containing IRF-3 with its DNA2002), we focused on signaling molecules in the Trif-
dependent pathway. IRF-3 is a transcription factor in- binding domain deleted was created (IRF-3DBD). Ex-
pression of IRF-3 DBD in wt and p50/p52-deficientduced in the Trif-dependent pathway and has been
shown to play a role in IP-10 induction by LPS (Saka- cells was confirmed by Western analysis (Figure 5B, left
image). The IRF-3 DBD cells were then infected withguchi et al., 2003; Yamamoto et al., 2003). Furthermore,
an interaction between IRF-3 and p65 has been demon- the ML I1I2 transgene and stimulated with TNF over a
6 hr time course. Expression of IRF-3 DBD rescued thestrated (Wietek et al., 2003).
A retrovirus expressing the IRF-3 cDNA was created induction of the ML I1I2 transgene in p50/p52-deficient
cells (Figure 5B, right image).and used to infect wt and p50/p52-deficient cells. Over-
expression of IRF-3 protein was confirmed by Western To confirm that IRF-3 is required for LPS stimulation
of the ML I1I2 transgene in p50/p52-deficient cells, weanalysis (Figure 5A, left image). IRF-3 overexpressing
cells were then infected with the ML I1I2 transgene and created a retrovirus expressing an RNAi cassette
against IRF-3 to silence the endogenous IRF-3 expres-stimulated with TNF over a 6 hr time course. Overex-
pression of IRF-3 rescued the induction of the ML I1I2 sion (Qin et al., 2003). IRF-3 protein levels were con-
firmed by Western analysis and were knocked downtransgene in p50/p52-deficient cells (Figure 5A, right
image). This result also supports the interpretation of approximately 3–4-fold (Figure 5C, left image). p50/p52-
deficient cells with IRF-3 knocked-down were infectedthe ChIP data that p65 was bound to the identified func-
tional B sites and not cryptic elements. with the ML I1I2 transgene, stimulated with LPS, and
assayed for luciferase induction. The absence of IRF-3Since the MCP-1 promoter does not contain an IRF-3
binding site, it seemed likely that IRF-3 is serving as a in LPS-stimulated p50/p52-deficient cells abrogated the
induction of the ML I1I2 transgene (Figure 5C, rightcoactivator in this situation. Previous work has shown
that the c-Myc transcription factor can bind and activate image).
As mentioned earlier, endogenous IP-10 requiresa number of promoters, which contain no apparent
Transcriptional Specificity of NF-B Dimers
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Figure 6. Induction of ML I1I2 by TNF Re-
quires Bcl-3
Bcl-3-deficient and wild-type (wt) cells are
stimulated with TNF or LPS over a four hour
time course. Induction of endogenous IP-10
and MCP-1 RNA transcript levels are mea-
sured by quantitative PCR (A). Bcl-3 KO and
wt cells carrying the ML I1I2 or ML M1M2
transgene are stimulated with TNF over a
four hour time course (B).
IRF-3 for gene activation. We have demonstrated that response to TNF? Might there be another coactivator
that suffices in wt cells where the p65:p50 heterodimerthe B site sequence can alter the configuration of
bound p65:p65 homodimers to implement an IRF-3 re- predominates? We were drawn to the observation that
Bcl-3, an IB-like protein that interacts preferably withquirement for transgene activation. Does the change in
B site sequence alter the configuration of all B dimers p50 or p52, can serve as a coactivator (Franzoso et al.,
1992; Fujita et al., 1993).such that the ML I1I2 transgene requires IRF-3 for gene
activation in wt cells, where the major species of NF-B To examine the possibility that Bcl-3 is critical to IP-
10 induction in wt cells, Bcl-3-deficient cells were stimu-is p65:p50 heterodimers? Using the same retrovirus, we
knocked down IRF-3 in wt cells (Figure 5D, left image). lated with TNF over a 4 hr time course. RNA transcript
levels of endogenous IP-10 and MCP-1 were measuredThe absence of IRF-3 in LPS-stimulated wt cells also
abrogated the induction of the ML I1I2 transgene (Figure by Q-PCR. IP-10 induction was absent in Bcl-3-deficient
cells, while MCP-1 induction recapitulated wt levels (Fig-5D, right image). To further confirm these findings, the
absence of IRF-3 in TNF-stimulated wt cells did not ure 6A). Thus, in TNF-stimulated cells, IP-10 is a Bcl-
3-dependent gene. As expected, when Bcl-3-deficientaffect the induction of IP-10 or the ML I1I2 transgene
(data not shown). cells were infected with the ML I1I2 transgene and stimu-
lated with TNF over a 4 hr time course, minimal lucifer-
ase induction was observed, showing that the Bcl-3IRF-3 Is Recruited to I1I2 B Binding Sites
To test whether IRF-3 is directly recruited to the ML I1I2 dependence is a consequence of the B site sequence
(Figure 6B, left image). In contrast, the ML M1M2 trans-transgene, ChIP assays were performed with an anti-
IRF-3 antibody in LPS-stimulated, IRF-3 overexpress- gene was induced to similar levels in wt and Bcl-3-
deficient cells (Figure 6B, right image). Finally, inductioning, wt cells. We found that IRF-3 was bound to the
IP-10 promoter but not the MCP-1 promoter in an LPS- of IP-10 expression in LPS-stimulated Bcl-3-deficient
cells remained intact (data not shown).dependent manner (Figure 5E, left image). Furthermore,
IRF-3 was also bound to the ML I1I2 transgene (Figure
5E, right image). Therefore, IP-10’s B site sequences Discussion
are able to recruit IRF-3 to a promoter.
IP-10’s requirement for IRF-3 in p50/p52-deficient In our previous study, no direct correlation between the
B site sequence and B family member requirementscells can explain the stimulus-specific requirements for
B family members. Under LPS stimulation, p65 homodi- for gene activation could be found (Hoffmann et al.,
2003). There we compared one gene to another butmers appear to interact with IRF-3 to activate the ML
I1I2 transgene. Under TNF stimulation, IRF-3 is not when, in this study, we made interspecies comparisons
of the same gene, we found a remarkable constancy ofactivated and the p65 homodimers, although bound, are
unable to function and the ML I1I2 transgene is not sequence, implying that the individual sequences have
important characteristics. This led us to examine theactivated. For LPS-stimulated wt cells, we demon-
strated that p65:p50 heterodimers appear to interact role of the particular sequences found associated with
particular genes. To do this we developed a lentiviralwith IRF-3 to activate the ML I1I2 transgene. This result
implies that the B site sequence can change the config- system for incorporating regulatory sequences into cel-
lular DNA. Then, by swapping the B site sequencesuration of heterodimers, not just p65 homodimers. Fi-
nally, we show that IRF-3 is directly recruited to the ML within the MCP-1 promoter to the B site sequences
for the IP-10 gene, we found that we could impose IP-I1I2 promoter in a stimulus-dependent manner.
10’s B family member requirements onto the MCP-1
promoter. Both IP-10 B site sequences had to be trans-IP-10 Requires Bcl-3 for Induction by TNF
The need for IRF-3 provides an explanation for why IP- ferred to change B family member requirements and
revealed that two B sites can function together as a10 is induced in p50/p52-deficient cells only in response
to LPS but not TNF. Why do wt cells express IP-10 in module to regulate gene activation. This suggested that
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either MCP-1 site was dominant over the two IP-10 sites. different and nonredundant roles. This postulate leads
us to a model that the two B sites serve different andBy doing chromatin immunoprecipitation experiments,
we found that even though the I1 site would not work jointly obligate functions.
In LPS-stimulated p50/p52-deficient cells infectedwith the p65 homodimer, the IP-10 B sites did bind the
homodimer which, in turn, even bound the coactivator with the ML M1M2 transgene, we know that p65 homodi-
mers are bound to the B sites along with p300/CBPCBP/p300. We then found that the IP-10 requirement
for a B heterodimer for activation by TNF is not evident (data not shown) and drive luciferase expression. Our
postulate that the two sites serve different functionsafter LPS stimulation. This suggested that the B site
specificity operated by imposing on the DNA bound NF- leads us to suppose that only one B homodimer binds
p300 and that the other binds an unknown factor X butB, a cofactor requirement for activation. In fact, we
showed that the ML I1I2 transgene requires Bcl-3 when other explanations are conceivable (Figure 7A). In LPS-
stimulated p50/p52-deficient cells infected with the MLstimulated by TNF and that IRF-3 can play this role
in p50/p52-deficient cells where Bcl-3 is not able to I1I2 transgene, we postulate that the I2 site continues
to bind p300/CBP but the I1 B site sequence alters thefunction. Because IRF-3 is induced by LPS but not TNF,
the role of this B site specificity is explained. We ex- p65 homodimer conformation such that another cofac-
tor must take the place of X. IRF-3 can serve this functiontended the analysis to show that the IRF-3 requirement
for LPS-stimulated ML I1I2 transgene activity applies to and in LPS-induced cells, it binds and cooperates to
drive luciferase expression (Figure 7B). In TNF-stimu-p50:p65 heterodimers as well. Therefore, the B site
sequence affects the configuration of both heterodimers lated p50/p52-deficient cells with the ML M1M2 trans-
gene, the situation is similar to that in LPS-simulatedand p65 homodimers. Finally, we showed that IRF-3 is
recruited to the ML I1I2 promoter. The sequence alter- cells (Figure 7C). However, in the TNF-stimulated p50/
p52-deficient cells with the ML I1I2 transgene, theation that imposes the coactivator requirement is a sin-
gle nucleotide in the sixth position of the B site—it is change in the I1 B site sequence alters the conforma-
tion for p65 homodimers such that they require a cofac-quite remarkable that such a change can impose on a
gene a new cofactor requirement that is fulfilled only tor of a type that is simply not present in the cells.
Instead, onlyB heterodimers are able to drive transcrip-under particular circumstances.
tion because of the requirement for the second activity is
supplied by Bcl-3 binding to the p50 subunit (Figure 7D).How Is Specificity Imposed?
There are three models for how the single nucleotide
difference in the B site can impose such specificity. Advantages of a Lentiviral-Based
Reporter SystemOne model suggests that there is another protein bound
to the DNA site that requires this particular nucleotide. Our lentiviral-based reporter system is a novel approach
to study gene transcription. This system offers manyIt would most likely bind in conjunction with NF-B, just
as HMG I(Y) has been shown to bind to certain B sites advantages over current transcription reporter systems.
(1) The promoter of the gene of interest is integratedalong with NF-B (Falvo et al., 1995). The factor would
bind the distal IP-10 B site because that site dominantly into the cell’s DNA and should therefore be subject to
chromatin regulation. (2) Tandem copies of integrationimposes the heterodimer restriction. It seems a bit far-
fetched but not impossible that a protein could bind to are avoided to allow for faithful promoter regulation. (3)
Copy number of the transgene can be controlled. (4)the B site and then dominantly impose a restriction on
the functioning of a dimer that would be overcome by This system can be applied to nondividing and un-
transfectable cells. (5) Most importantly, the systema cofactor. IRF-3 and Bcl-3 would be the responsible
cofactors in LPS- and TNF-stimulated cells, respec- allows flexibility to conveniently modify promoter se-
quence by PCR. A limitation of this system is the amounttively.
Another possibility is that B dimers may oligomerize of DNA sequence one can place into the vector (roughly
7 kb). In truth, it is not possible to know for sure howwhen bound to their respective sites. The sequence of
the B site would determine oligomerization efficiency much regulatory DNA a particular gene requires so the
optimum method for studying promoters would be toand precise conformation of the overall structure. The
B tetramer would determine which cofactors would be make nucleotide changes in situ in the promoter regula-
tory elements using “knockin” technology (Xu et al.,needed for gene activation.
A likely possibility is that the particular distal IP-10 B 1996). Unfortunately, knockin or even BAC transgene
experiments (Lee et al., 2003) are difficult, time-consum-site imposes a configuration on the bound heterodimers
that establishes a requirement for Bcl-3. In the p50/ ing, and prohibitively expensive as a method to do a
systematic study, such as we have presented here. Ourp52-deficient cells, where Bcl-3 cannot bind the p65
homodimers, the requirement for a coactivator can be approach represents an effective compromise between
the ideal and need for extensive experimental manipu-supplied by IRF-3, which can bind to p65 (Wietek et
al., 2003). lation.
B Site Sequence Determines NF-B FamilyPotential Model
To fully explain our data, we return to the observation Member Requirements
In our previous study, we documented that B-depen-that two B sites are needed for the MCP-1 promoter
to function. The stimulus and subunit specificities have dent genes require specific B family members for func-
tional activation (Hoffmann et al., 2003). Here, we dem-been explained by the role of one B site, but why then
do we need two? We suspect that the two sites serve onstrate that the sequence of the B site is responsible
Transcriptional Specificity of NF-B Dimers
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Figure 7. Two B Sites Function Together to
Determine NF-B Family Member and Coacti-
vator Specificity
A model depicting how two B sites could
coordinate as a single module to regulate
gene activation. The model postulates that
the two B sites in a promoter/enhancer have
separable functions that must be jointly pro-
vided from the module to support transcrip-
tion. One is to bind p300/CBP, the other is to
bind a second coactivator whose nature is
dictated by the sequence of the B site to
which that NF-B dimer is bound. One hypo-
thetical coactivator is designated X, the oth-
ers are known. The model is presented in the
context of 4 conditions discussed in the text.
In LPS-stimulated p50/p52-deficient cells,
p65 homodimers bound to M1 and M2 recruit
p300/CBP and X (A). In the same cells, the
alteration to I1 does not allow X binding
but does support IRF-3 binding (B). In TNF-
stimulated p50/p52-deficient cells infected
with ML M1M2, the situation is similar to that
in LPS-stimulated cells (C). However, in
TNF-stimulated p50/p52-deficient cells in-
fected with ML I1I2, because IRF-3 is not activated, the p65 homodimers cannot bind a coactivator and gene activation does not occur (not
shown). However, in wild-type cells, NF-B heterodimers are present and p50 is able to bind Bcl-3, providing the co-activator needed for the
module to function (D).
for determining NF-B dimer specificity, and two B recent structural studies support this conclusion. Com-
parisons of p50:p65 dimers bound to different B sitesbinding sites can function together to regulate gene
activation. This regulation does not occur at the level sequences have revealed significant differences in their
conformation (Chen-Park et al., 2002). These differencesof B dimer exclusion. In fact, we found inducible p65
recruitment to a functionally inactive promoter. Instead, in conformation have been correlated to their ability to
transactivate transfected reporter plasmids. Therefore,we believe that the sequence of the B site contains
information that is interpreted by the bound B dimer, our notion that it is coactivator binding which determines
specificity is supported by prior structural studies show-changes the B dimer configuration, and determines
which coactivators will form functional interactions with ing alternate conformations induced allosterically by dif-
ferent DNA binding site sequences.the B dimer.
How many functionally different B sites might there In other families of transcription factors, there is also
evidence that DNA can act as an allosteric regulator. Itbe? We can presently identify three different types. In
our system, M1 or M2 behave identically and we postu- has been best studied with the glucocorticoid receptor
(GR) (Lefstin and Yamamoto, 1998). The DNA bindinglate that they bind factor “X”. A key property of this
class of B site is that it is dominant over other sites. domain of GR can bind its cognate site in a variety of
conformations depending on the sequence of the site,The second class is I1, a site that requires IRF-3 or Bcl-3
coactivators for activation when it is coupled to I2 or is serving to present different interfaces for the recruitment
of specific cofactors and to help determine whetherused in tandem. I1 differs from M1 and M2 at only one
position, nucleotide 6. Finally, the I2 site is in a category the bound factor will activate or repress transcription.
Recent work has identified which GR surfaces are re-by itself. It must require a coactivator different from M1
or M2 that is not dominant over I1. It is notable that I2 quired in a gene-specific manner (Rogatsky et al., 2002,
2003). Similar findings have also been reported for thehas two nucleotides, at positions 5 and 8, different from
both M2 and I1. There is every reason to expect that POU family of proteins (Phillips and Luisi, 2000).
The prevailing model of gene transcription is that onthere are other B sites with specificities yet to be identi-
fied. From our limited evolutionary survey in Figure 1A, a given promoter multiple proteins must interact, assem-
ble, and form an enhanceosome to activate gene tran-we see 12 different sites all of which are conserved
between mouse and human. It could be that these 12 scription (Thanos and Maniatis, 1995b). If one factor is
absent, the gene is not activated. Numerous examplesand others are all serving specific functions, going a
long way to providing the breadth of diversity needed of NF-B’s role in this model exist, most notably on the
HIV-LTR, IFN-, and IL-2 promoters (Perkins et al., 1993,to understand how B sites can be found in so many
different genes which are regulated in specific ways 1994; Rothenberg and Ward, 1996; Thanos and Ma-
niatis, 1995b). Furthermore, chromatin has also been(Hoffmann et al., 2003).
implicated as having a role in determining NF-B’s ac-
cess to DNA binding sites and may do so in a B dimer-B Site Sequence Determines
Coactivator Requirements specific fashion (Saccani et al., 2001, 2003). In the best-
studied system, the IFN- gene, there is only one BIt is impressive that changing one base pair would have
such a dramatic effect on gene regulation. However, site and that is why it may be so complex. In vitro binding
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and transient transfection studies demonstrated that the regulation profile into IP-10’s. We speculate that in a
mouse this would severely disrupt the delicate balanceB site sequence is important, presumably to coordinate
the binding of both NF-B and HMG (I)Y (Thanos and between innate and adaptive immunity. Our results un-
derscore the functional importance of the sequence ofManiatis, 1995a). As we imply by the models in Figure
7, where there are two B sites, the situation may be the B site and confirm why the sequence of B sites
is strictly conserved over time. Not only does the Bdifferent because there can be two interacting com-
plexes formed around two NF-B dimers. site sequence determine B dimer specificity, it also
determines coactivator requirements.
Bcl-3 Requirement
Experimental ProceduresTNF activation of IP-10 activation requires Bcl-3, and
our data implies that p50:p65 heterodimers interact with Cell Culture and Time Courses
Bcl-3. Previous studies have shown that Bcl-3 preferen- Immortalized cell lines were generated and maintained as previ-
tially interacts with p50 or p52 homodimers and not with ously described (Hoffmann et al., 2003). 100% confluent cells were
treated for 48 hr with 0.5% serum containing medium and then stim-p50:p65 heterodimers (Franzoso et al., 1992; Fujita et
ulated with the appropriate concentration of TNF (4 ng/mL) or LPSal., 1993). We can suggest three potential mechanisms
(0.5 	g/mL) over a period of 4–6 hr.to explain this apparent discrepancy. First, even though
the major constituent of NF-B in wild-type fibroblasts is
Plasmids
p50:p65 heterodimers, a significant amount of p50:p50 To generate ML M1M2, 5 kB of the MCP-1 promoter was amplified
homodimers exist and could bind one of the two sites by PCR from a BAC clone. The resulting fragment was cloned into
FugW (Lois et al., 2002). To generate IL, 967 bp of IP-10 promoterto interact with Bcl-3 to activate IP-10. Second, it may
(939 -28) was amplified by PCR and cloned into FugW. Variationsbe possible that p50:p65 heterodimers can interact with
of ML plasmid were constructed by PCR mutagenesis. IRF-3 andBcl-3 to activate IP-10 expression. Third, as mentioned
IRF-3 DBD expression plasmids were generated by amplifyingearlier, p50:p65 heterodimers may oligomerize when
IRF-3 (amino acids 1–420) and IRF-3 DBD (133–420) by PCR and
bound to their respective sites. The p50 subunits from cloning into the pBABE-neo vector (Morgenstern and Land, 1990).
each heterodimer could conceivably interact and recruit All plasmids were verified by DNA sequencing and restriction di-
gest analysis.Bcl-3.
Real-Time PCRBiology
Total RNA was made from confluent and starved fibroblasts using
MCP-1 and IP-10 are differentially regulated, presum- TriReagent (Molecular Research Center, Inc.). cDNA was synthe-
ably because they serve different functions. MCP-1 sized with Superscript II (Invitrogen) following manufacturer’s guide-
plays a significant role in innate immunity by bringing lines and 100 ng total RNA as a starting amount. Q-PCR was per-
formed using Sybr Green PCR Master Mix (Applied Biosystems)macrophages to sites of inflammation. On the other
and a 5600 Real-Time PCR machine (Applied Biosystems). Sampleshand, IP-10 is important for lymphocytic (adaptive) im-
were performed in triplicates, and GAPDH transcript levels weremunity and regulates T cell proliferation. MCP-1 is also
used to normalize between samples. Every experiment was per-
activated by a more diverse set of TLR agonists than formed at least twice, many three to six times with high reproducibil-
IP-10. For example, TLR-2 agonists stimulate MCP-1, ity. Primer sequences are available upon request.
but not IP-10 expression (Pierer et al., 2004; Re and
Reporter AssayStrominger, 2001). Recent studies reveal that MCP-1
Luciferase assay was performed as described elsewhere (Pomer-and IP-10 are regulated differently during TLR-4 stimula-
antz and Baltimore, 1999). Samples were normalized for proteintion (Sakaguchi et al., 2003; Serbina et al., 2003; Yama-
levels by Bradford assay. Every experiment was performed at leastmoto et al., 2003). IP-10 is activated through TLR-4 via
twice, most three to five times with high reproducibility.
a Trif-dependent pathway. The Trif-dependent pathway
activates the interferon-response pathway and is re- Chromatin Immunoprecipitation
sponsible for a late NF-B activation (Yamamoto et al., ChIP studies were based on a combination of published protocols
(Boyd and Farnham, 1999; Boyd et al., 1998; Nissen and Yamamoto,2003). It has been shown that this pathway regulates a
2000; Saccani et al., 2001). p65 and IRF-3 antibodies were pur-specific subset of TLR3/TLR4-dependent genes, and
chased from Santa Cruz Biotechnologies (sc-109) and Zymed Labo-that the pathway is evolutionarily diverged from other
ratories, respectively. p300 antibody was a gift from Kevin Gardner.
members of the TLR family (Doyle et al., 2002). In con- Sequences of promoter-specific primers and our detailed protocol
trast, MCP-1 is activated by both the MyD88-dependent are available upon request.
and Trif-dependent pathways. The MyD88 pathway dif-
Lentivirusfers from the Trif pathway in two ways. First, it does
Lentivirus was produced as described elsewhere (Lois et al., 2002).not activate the interferon-response pathway. Second,
it activates NF-B much earlier than the Trif pathway.
siRNAThese two pathways normally work together to ready FG12 RNAi vector and production of siRNA was previously de-
an immune response to a bacterial pathogen. A bacterial scribed elsewhere (Qin et al., 2003). The IRF-3-siRNA contains the
pathogen would signal the TLR-4 receptor and activate sense targeting sequence of gacgcacagatggctgact corresponding
to the 390–407 nucleotide positions of the mouse IRF-3 coding se-both downstream pathways. The MyD88 pathway would
quence.activate NF-B immediately to drive MCP-1 production
and recruit macrophages to the target site. Later, the
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